NCT05744557View on ClinicalTrials.gov

Vapocoolant Analgesia for Breast Lymphoscintigraphy

NATerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

May 13, 2025

Study Completion Date

May 13, 2025

Conditions
Breast Cancer
Interventions
OTHER

num Vapocoolant

Spray will be administered for 4 to 6 seconds from a distance of 3 to 6 inches to desired sites of skin

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Gilero, LLC
All Listed Sponsors
collaborator

Gilero, LLC

UNKNOWN

lead

M.D. Anderson Cancer Center

OTHER

NCT05744557 - Vapocoolant Analgesia for Breast Lymphoscintigraphy | Biotech Hunter | Biotech Hunter